Skip to main content

Find Clinical Trials

Home
Conditions
Chronic Lymphocytic Leukemia

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

528 public trials 91 recruiting studies

Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions: Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations: Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom

Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom

University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom

Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom

View Trial Details

Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations: City of Hope ( Site 0010) Duarte, California, United States

University of California - San Diego ( Site 0003) La Jolla, California, United States

UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States

University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States

View all 14 locations

View Trial Details

Completed

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

NCT05028374

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +28 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

NCT03734601

Conditions: Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +33 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

NCT00571662

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +40 more
Locations: University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States

View Trial Details

Completed

A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02005471

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University of California San Diego Medical Center La Jolla, California, United States

Henry Ford Health System Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center; Clinical Trials Office New York, United States

Perlmutter Cancer Center NYU Langone Health New York, United States

View all 111 locations

View Trial Details

Completed

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

NCT03096782

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Allo HSCT Using RIC for Hematological Diseases

NCT02661035

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, B-cell Lymphoma, +59 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07

NCT02049515

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: La Jolla, California, United States

Denver, Colorado, United States

Fort Myers, Florida, United States

St. Petersburg, Florida, United States

View all 69 locations

View Trial Details